PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AVBP vs. SMH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between AVBP and SMH is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

AVBP vs. SMH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ArriVent BioPharma Inc. Common Stock (AVBP) and VanEck Vectors Semiconductor ETF (SMH). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
12.32%
6.17%
AVBP
SMH

Key characteristics

Sharpe Ratio

AVBP:

0.53

SMH:

0.71

Sortino Ratio

AVBP:

1.05

SMH:

1.14

Omega Ratio

AVBP:

1.13

SMH:

1.15

Calmar Ratio

AVBP:

0.86

SMH:

1.04

Martin Ratio

AVBP:

1.56

SMH:

2.41

Ulcer Index

AVBP:

18.00%

SMH:

10.72%

Daily Std Dev

AVBP:

53.27%

SMH:

36.27%

Max Drawdown

AVBP:

-32.75%

SMH:

-83.29%

Current Drawdown

AVBP:

-24.50%

SMH:

-10.77%

Returns By Period

In the year-to-date period, AVBP achieves a 0.98% return, which is significantly lower than SMH's 3.18% return.


AVBP

YTD

0.98%

1M

5.84%

6M

12.32%

1Y

22.83%

5Y*

N/A

10Y*

N/A

SMH

YTD

3.18%

1M

1.09%

6M

6.26%

1Y

23.60%

5Y*

27.98%

10Y*

25.86%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AVBP vs. SMH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVBP
The Risk-Adjusted Performance Rank of AVBP is 6464
Overall Rank
The Sharpe Ratio Rank of AVBP is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of AVBP is 5959
Sortino Ratio Rank
The Omega Ratio Rank of AVBP is 5757
Omega Ratio Rank
The Calmar Ratio Rank of AVBP is 7676
Calmar Ratio Rank
The Martin Ratio Rank of AVBP is 6262
Martin Ratio Rank

SMH
The Risk-Adjusted Performance Rank of SMH is 3030
Overall Rank
The Sharpe Ratio Rank of SMH is 2525
Sharpe Ratio Rank
The Sortino Ratio Rank of SMH is 2727
Sortino Ratio Rank
The Omega Ratio Rank of SMH is 2828
Omega Ratio Rank
The Calmar Ratio Rank of SMH is 4242
Calmar Ratio Rank
The Martin Ratio Rank of SMH is 2626
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AVBP vs. SMH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ArriVent BioPharma Inc. Common Stock (AVBP) and VanEck Vectors Semiconductor ETF (SMH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AVBP, currently valued at 0.53, compared to the broader market-2.000.002.004.000.530.64
The chart of Sortino ratio for AVBP, currently valued at 1.05, compared to the broader market-6.00-4.00-2.000.002.004.001.051.05
The chart of Omega ratio for AVBP, currently valued at 1.13, compared to the broader market0.501.001.502.001.131.14
The chart of Calmar ratio for AVBP, currently valued at 0.86, compared to the broader market0.002.004.006.000.860.93
The chart of Martin ratio for AVBP, currently valued at 1.56, compared to the broader market0.0010.0020.0030.001.562.15
AVBP
SMH

The current AVBP Sharpe Ratio is 0.53, which is comparable to the SMH Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of AVBP and SMH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.300.400.500.600.700.800.90Fri 31FebruaryFeb 02Mon 03Tue 04Wed 05Thu 06Fri 07Sat 08Feb 09Mon 10Tue 11Wed 12
0.53
0.64
AVBP
SMH

Dividends

AVBP vs. SMH - Dividend Comparison

AVBP has not paid dividends to shareholders, while SMH's dividend yield for the trailing twelve months is around 0.43%.


TTM20242023202220212020201920182017201620152014
AVBP
ArriVent BioPharma Inc. Common Stock
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SMH
VanEck Vectors Semiconductor ETF
0.43%0.44%0.60%1.18%0.51%0.69%1.50%1.88%1.43%0.80%2.14%1.16%

Drawdowns

AVBP vs. SMH - Drawdown Comparison

The maximum AVBP drawdown since its inception was -32.75%, smaller than the maximum SMH drawdown of -83.29%. Use the drawdown chart below to compare losses from any high point for AVBP and SMH. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-24.50%
-10.77%
AVBP
SMH

Volatility

AVBP vs. SMH - Volatility Comparison

ArriVent BioPharma Inc. Common Stock (AVBP) has a higher volatility of 13.68% compared to VanEck Vectors Semiconductor ETF (SMH) at 12.71%. This indicates that AVBP's price experiences larger fluctuations and is considered to be riskier than SMH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
13.68%
12.71%
AVBP
SMH
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab